Sensex, Nifty End Week Higher as Financials, Pharma Stocks Shine.
Indian equity benchmarks wrapped up the week on a positive note on Friday, led by strong gains in financial and pharmaceutical stocks. Cipla, State Bank of India, and ICICI Bank were among the top performers on the Nifty50 as volatility eased after a choppy few sessions.
The S&P BSE Sensex rose 328.72 points to close at 82,500.82, while the NSE Nifty50 gained 103.55 points to settle at 25,285.35. Broader market indices also advanced, reflecting renewed buying interest ahead of the festive season. Sentiment remained upbeat, buoyed by firm global cues and steady institutional inflows. Financials, autos, and pharma stocks led the uptrend, helping benchmarks rebound from midweek consolidation.
Vinod Nair, Head of Research at Geojit Financial Services, said optimism in the banking and pharma sectors drove the rally. “Investor sentiment improved after the government invited private sector professionals to lead State Bank of India,” Nair noted, calling it “a step toward greater efficiency and governance in public sector enterprises.”
Pharma shares also surged after the US revived the Biosecure Act, a move aimed at reducing biotech ties with Chinese firms — a potential boost for Indian CDMO players. Rupak De, Senior Technical Analyst at LKP Securities, said the Nifty’s breakout above its consolidation range signals further strength.
“The setup looks favorable for a continued rise in the short term. Any dip could offer a buying opportunity,” he said.
He expects resistance around 25,500–25,550, with support near 25,150.
Analysts remain cautiously optimistic about the near-term outlook, citing strong sectoral trends and festive season tailwinds. However, they warn that intermittent profit-booking may occur after the recent run-up. Dalal Street ended the week on firm ground, with traders eyeing 25,500 as the next key level for Nifty amid easing volatility and supportive global cues.
Comments are closed.